Trend of human rabies prophylaxis in developing countries: Toward optimal rabies immunization

Nitipong Permpalung, Supakanya Wongrakpanich, Sira Korpaisarn, Pansakorn Tanratana, Jaruboot Angsanakul

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations


Rabies is a fatal infectious disease. Because prevention is the key management for rabies, many vaccination regimens have been developed and used worldwide. The aims for developing rabies vaccination regimens include decreasing the number and amount of dosages, decreasing the duration and the number of clinical visits, and reducing cost. Interestingly, some intradermal (ID) regimens have proved to be as effective as the standard intramuscular (IM) regimens, and have been increasingly used in developing countries because they are less expensive. In this article, we reviewed rabies vaccines based on results obtained from clinical trials and international treatment guidelines for post-exposure prophylaxis, pre-exposure prophylaxis for the high risk group, and booster vaccination.

Original languageEnglish (US)
Pages (from-to)4079-4083
Number of pages5
Issue number38
StatePublished - Aug 28 2013
Externally publishedYes


  • Developing countries
  • Prophylaxis
  • Rabies
  • Vaccine

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'Trend of human rabies prophylaxis in developing countries: Toward optimal rabies immunization'. Together they form a unique fingerprint.

Cite this